Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Social equity in Human Papillomavirus vaccination: a natural experiment in Calgary Canada.

Musto R, Siever JE, Johnston JC, Seidel J, Rose MS, McNeil DA.

BMC Public Health. 2013 Jul 9;13:640. doi: 10.1186/1471-2458-13-640.

2.

Citizen intervention in a religious ban on in-school HPV vaccine administration in Calgary, Canada.

Guichon JR, Mitchell I, Buffler P, Caplan A.

Prev Med. 2013 Nov;57(5):409-13. doi: 10.1016/j.ypmed.2013.06.005. Epub 2013 Jun 13.

PMID:
23769899
3.

[HPV vaccination coverage in German girls: results of the KiGGS study: first follow-up (KiGGS Wave 1)].

Poethko-Müller C, Buttmann-Schweiger N; KiGGS Study Group.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jul;57(7):869-77. doi: 10.1007/s00103-014-1987-3. German.

PMID:
24950836
4.

Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada.

McClure CA, MacSwain MA, Morrison H, Sanford CJ.

Vaccine. 2015 Apr 8;33(15):1786-90. doi: 10.1016/j.vaccine.2015.02.047. Epub 2015 Feb 27.

5.

Human papillomavirus vaccination in Auckland: reducing ethnic and socioeconomic inequities.

Poole T, Goodyear-Smith F, Petousis-Harris H, Desmond N, Exeter D, Pointon L, Jayasinha R.

Vaccine. 2012 Dec 17;31(1):84-8. doi: 10.1016/j.vaccine.2012.10.099. Epub 2012 Nov 8.

PMID:
23142131
6.

A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.

Hutubessy R, Levin A, Wang S, Morgan W, Ally M, John T, Broutet N.

BMC Med. 2012 Nov 13;10:136. doi: 10.1186/1741-7015-10-136.

7.

Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study.

Lim WT, Sears K, Smith LM, Liu G, Lévesque LE.

BMC Public Health. 2014 Oct 3;14:1029. doi: 10.1186/1471-2458-14-1029.

8.

Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.

Watson M, Shaw D, Molchanoff L, McInnes C.

Aust N Z J Public Health. 2009 Aug;33(4):365-70. doi: 10.1111/j.1753-6405.2009.00409.x.

PMID:
19689598
9.

Achieving high and equitable coverage of adolescent HPV vaccine in Scotland.

Sinka K, Kavanagh K, Gordon R, Love J, Potts A, Donaghy M, Robertson C.

J Epidemiol Community Health. 2014 Jan;68(1):57-63. doi: 10.1136/jech-2013-202620. Epub 2013 Aug 28.

PMID:
23986492
10.

A school-based human papillomavirus vaccination program in barretos, Brazil: final results of a demonstrative study.

Fregnani JH, Carvalho AL, Eluf-Neto J, Ribeiro Kde C, Kuil Lde M, da Silva TA, Rodrigues SL, Mauad EC, Longatto-Filho A, Villa LL.

PLoS One. 2013 Apr 24;8(4):e62647. doi: 10.1371/journal.pone.0062647. Print 2013.

11.

Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program.

Pearson AL, Kvizhinadze G, Wilson N, Smith M, Canfell K, Blakely T.

BMC Infect Dis. 2014 Jun 26;14:351. doi: 10.1186/1471-2334-14-351.

12.

Qualitative study of the feasibility of HPV vaccine delivery to young adolescent girls in Vietnam: evidence from a government-implemented demonstration program.

LaMontagne DS, Nghi NQ, Nga le T, Janmohamed A, Huyen DT, Hien NT, Tsu VD.

BMC Public Health. 2014 Jun 5;14:556. doi: 10.1186/1471-2458-14-556.

13.

Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013.

Ladner J, Besson MH, Rodrigues M, Audureau E, Saba J.

BMC Public Health. 2014 Jun 30;14:670. doi: 10.1186/1471-2458-14-670.

14.

Early lessons learned from extramural school programs that offer HPV vaccine.

Hayes KA, Entzel P, Berger W, Caskey RN, Shlay JC, Stubbs BW, Smith JS, Brewer NT.

J Sch Health. 2013 Feb;83(2):119-26. doi: 10.1111/josh.12007.

PMID:
23331272
15.

Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents.

Hansen BT, Campbell S, Burger E, Nygård M.

Prev Med. 2015 Aug;77:4-10. doi: 10.1016/j.ypmed.2015.04.024. Epub 2015 May 3.

16.

Successful implementation and results of an HPV vaccination program in Geneva Canton, Switzerland.

Jeannot E, Petignat P, Sudre P.

Public Health Rep. 2015 May-Jun;130(3):202-6.

PMID:
25931623
17.

Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program.

Paul P, Fabio A.

Vaccine. 2014 Jan 9;32(3):320-6. doi: 10.1016/j.vaccine.2013.11.070. Epub 2013 Dec 2. Review.

PMID:
24295804
18.

Socioeconomic predictors of human papillomavirus vaccination among girls in the Danish childhood immunization program.

Slåttelid Schreiber SM, Juul KE, Dehlendorff C, Kjær SK.

J Adolesc Health. 2015 Apr;56(4):402-7. doi: 10.1016/j.jadohealth.2014.12.008. Epub 2015 Feb 4.

PMID:
25659994
19.

Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of grade 8 girls.

Smith LM, Brassard P, Kwong JC, Deeks SL, Ellis AK, Lévesque LE.

BMC Public Health. 2011 Aug 13;11:645. doi: 10.1186/1471-2458-11-645.

20.

Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs.

Nodulman JA, Starling R, Kong AS, Buller DB, Wheeler CM, Woodall WG.

J Sch Health. 2015 May;85(5):289-98. doi: 10.1111/josh.12253.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk